STOCK ANALYSIS
WEEKLY FORECAST
FINANCIAL NEWS
Walmart to reduce workforce at select US E-commerce warehouses

As Walmart braces for a more challenging year ahead and steps up investment in automation, the big-box giant is laying off hundreds of employees at nationwide e-commerce facilities, according to a company statement Thursday.

Nio shares surge amid CFO's strong confidence in 250K sales target

According to Chief Financial Officer Steven Feng, Nio Inc. is "very confident" of meeting its target of doubling sales to 250,000 electric vehicles in 2023, prompting shares of the Chinese electric vehicle maker to surge in Hong Kong.

Carvana Soars on Bond Exchange Strategy, bondholders oppose plans

On Wednesday, Carvana said it would offer to exchange as much as $1 billion of its unsecured bonds at discount prices in an effort to extend looming repayment deadlines, sending shares of the Phoenix-based e-commerce company up nearly 20%.

Nike Surpasses Forecasts with a 14% Sales Increase Year-over-Year

Footwear and apparel maker, Nike Inc., beat revenue and profit expectations on double-digit sales gains for its holiday quarter earnings, even though its bloated inventory continued to weigh on its margins and sales in China fell short of estimates.

UBS shares climb amid growing optimism following Credit Suisse acquisition

As investor optimism about the takeover of its largest rival, Credit Suisse gathered pace, UBS Group AG jumped as much as 10% Tuesday, on track for its biggest gain since March 2020.

Moderna's US Covid shot deal sufficiently paid, says executive

While the COVID-19 pandemic ended up being a cash cow for several pharma and biotech companies, Moderna Inc., on Monday, said it now expects to price its COVID-19 vaccine at around $130 per dose in the US going forward.

Starbucks' new CEO assumes leadership earlier than planned, succeeding Howard Schultz

On Monday, Starbucks Corp. said it handed the reins to its incoming chief executive officer, Laxman Narasimhan, nearly two weeks earlier than expected.

Baidu shares soar after Enie Bot receives high praise from analysts

On Friday, Baidu Inc. experienced a surge of over 14% after various brokerages, including Citigroup, tested the company's recently revealed ChatGPT-like service and granted it provisional approval.

FedEx Shares Soar as Cost-Saving Measures Drive Up Profit Forecast

Following its efforts to reduce costs and offset a decrease in package volume, FedEx Corp's shares rose when the courier raised its profit forecast.

Adobe raises outlook following solid earings release, share climb

After Adobe posted quarterly earnings that topped its own guidance and Street estimates, shares of the content development and marketing software company rallied in late trading Wednesday.

"Deadpool" actor Ryan Reynolds strikes $1.35 billion deal with T-Mobile

T-Mobile, on Wednesday, confirmed it would buy Mint Mobile, the budget wireless provider backed by the "Deadpool" actor, for as much as $1.35 billion in a cash-and-stock deal.

Google brings generative AI to Gmail and Docs, more features to come

On Tuesday, Google introduced features that will let users create text in Gmail and Docs using the company's AI technology as the company battles for dominance in the burgeoning field with rivals like Microsoft Corp and OpenAI.

Meta announces more layoffs, to slash thousands of jobs and open positions

Warning that economic instability may continue for "many years," Meta CEO Mark Zuckerberg announced Tuesday the company would lay off 10,000 more workers and incur restructuring costs ranging from $3 billion to $5 billion.

First Republic Bank shares plunge 71% on the back of SVB collapse

As broader fears over the health of the US financial system following the collapse of Silicon Valley Bank outweighed news that the regional lender secured new financing, shares in First Republic Bank shed as much as 71% of their value in trading on Monday before trading was halted. 

Pfizer agrees to buy cancer drug-maker Seagan for $43 billion

Placing a significant bet on Seagan, Pfizer on Monday said it would pay $229 per share in a cash deal that values the biotech company at $43 billion and add innovative targeted therapies to its portfolio of cancer treatments.

Ready to get started?

Start trading with the full package, from start-of-the-art platform to free tool and favorable transaction fees.